KNSA
NASDAQ · Biotechnology
Kiniksa Pharmaceuticals Inte
$76.06
-0.45 (-0.59%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-4.4% upside
Low Target
$47.11
Average Target
$72.69
High Target
$100.82
Current Price
$76.06
Current
$76.06
$76.06
Target
$72.69
$72.69
$47.11
$72.69 avg
$100.82
Scenario Analysis
Bear Case
$47.11
-38.1%
Low target
Base Case
$72.69
-4.4%
Avg target
Bull Case
$100.82
+32.6%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$82.94
-8.3% from high
52-Week Low
$29.66
+156.4% from low
50-Day SMA
$42.51
+78.9% vs SMA
200-Day SMA
$35.71
+113.0% vs SMA
RSI (14)
68.7
Neutral
Target vs 52W High
$72.69
-12.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |